Considerations for Oral and Maxillofacial Surgeons in COVID-19 Era: Can We Sustain the Solutions to Keep Our Patients and Healthcare Personnel Safe?

• Authors: Radhika Chigurupati, Boston University; Neeraj Panchal, University of Pennsylvania; Andrew M. Henry, Boston University; Hussam Batal, Boston University; Amit Sethi, Boston University; Richard D'innocenzo, Boston University; Pushkar Mehra, Boston University; Deepak G. Krishnan, University of Cincinnati; Steven Roser, Emory University
• Journal Title: Journal of Oral Maxillofacial Surgery
• Volume: Volume 78, Number 8
• Publisher: Elsevier Inc. | 2020-08-01, Pages 1241-1256
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1016/j.joms.2020.05.027
• Subjects: Health Sciences, Public Health; Health Sciences, Medicine and Surgery; Health Sciences, Health Care Management
• Keywords: Science & Technology; Life Sciences & Biomedicine; Dentistry, Oral Surgery & Medicine; Coronavirus; Dynamics; Wuhan; China

Abstract

Several uncertainties exist regarding how we will conduct our clinical, didactic, business, and social activities as the coronavirus disease 2019 (COVID-19) global pandemic abates and social distancing guidelines are relaxed. We anticipate changes in how we interact with our patients and other providers, how patient workflow is designed, the methods used to conduct our teaching sessions, and how we perform procedures in different clinical settings. The objective of the present report is to review some of the changes to consider in the clinical and academic oral and maxillofacial surgery workflow and, allow for a smoother transition, with less risk to our patients and healthcare personnel. New infection control policies should be strictly enforced and monitored in all clinical and nonclinical settings, with an overall goal to decrease the risk of exposure and transmission. Screening for COVID-19 symptoms, testing when indicated, and establishing the epidemiologic linkage will be crucial to containing and preventing new COVID-19 cases until a vaccine or an alternate solution is available. Additionally, the shortage of essential supplies such as drugs and personal protective equipment, the design and ventilation of workspaces and waiting areas, the increase in overhead costs, and the possible absence of staff, if quarantine is necessary, must be considered. This shift in our workflow and patient care paths will likely continue in the short-term at least through 2021 or the next 12 to 24 months. Thus, we must prioritize surgery, balancing patient preferences and healthcare personnel risks. We have an opportunity now to make changes and embrace telemedicine and other collaborative virtual platforms for teaching and clinical care. It is crucial that we maintain COVID-19 awareness, proper surveillance in our microenvironments, good clinical judgment, and ethical values to continue to deliver high-quality, economical, and accessible patient care.